Purpose
Exposure of the general population to ionizing radiation has
increased in the past decades, primarily due to long distance travel and
medical procedures. On the other hand, accidental exposures, nuclear
accidents, and elevated threats of terrorism with the potential detonation
of a radiological dispersal device or improvised nuclear device in a major
city, all have led to increased needs for rapid biodosimetry and assessment
of exposure to different radiation qualities and scenarios. Metabolomics,
the qualitative and quantitative assessment of small molecules in a given
biological specimen, has emerged as a promising technology to allow for
rapid determination of an individual's exposure level and metabolic
phenotype. Advancements in mass spectrometry techniques have led to
untargeted (discovery phase, global assessment) and targeted (quantitative
phase) methods not only to identify biomarkers of radiation exposure, but
also to assess general perturbations of metabolism with potential long-term
consequences, such as cancer, cardiovascular, and pulmonary disease.
Conclusions
Metabolomics of radiation exposure has provided a highly informative
snapshot of metabolic dysregulation. Biomarkers in easily accessible
biofluids and biospecimens (urine, blood, saliva, sebum, fecal material)
from mouse, rat, and minipig models, to non-human primates and humans have
provided the basis for determination of a radiation signature to assess the
need for medical intervention. Here we provide a comprehensive description
of the current status of radiation metabolomic studies for the purpose of
rapid high-throughput radiation biodosimetry in easily accessible biofluids
and discuss future directions of radiation metabolomics research.